QQ客服 官方微博 反馈留言

	Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway
	Fan, Cheng; Li, Yuan; Yang, Hui; Cui, Yuqian; Wang, Hao; Zhou, Heng; Zhang, Jianning; Du, Binfeng; Zhai, Qian; Wu, Dawei
刊名	JOURNAL OF MOLECULAR HISTOLOGY
	2019
卷号	50期号:4页码:343-354
关键词	Tamarixetin Cardiac hypertrophy Remodeling Oxidative stress
DOI	10.1007/s10735-019-09831-1
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4546197
专题	山东大学
作者单位	1.Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Geriatr, Wuhan 430022, Hubei, Peoples R China. 2.[Li, Yuan 3.Wang, Hao 4.Zh
推荐引用方式 GB/T 7714	Fan, Cheng,Li, Yuan,Yang, Hui,et al. Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway[J]. JOURNAL OF MOLECULAR HISTOLOGY,2019,50(4):343-354.
APA	Fan, Cheng.,Li, Yuan.,Yang, Hui.,Cui, Yuqian.,Wang, Hao.,...&Chen, Xi 更多.(2019).Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway.JOURNAL OF MOLECULAR HISTOLOGY,50(4),343-354.
MLA	Fan, Cheng,et al."Tamarixetin protects against cardiac hypertrophy via inhibiting NFAT and AKT pathway".JOURNAL OF MOLECULAR HISTOLOGY 50.4(2019):343-354.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。